Riddle, M C <br/><br/>
Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.  [electronic resource] 

 -  Diabetes care  Jul 1998 
 - 1052-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.21.7.1052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--drug effects<br/>C-Peptide--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Diabetes Mellitus--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Fasting<br/>Female<br/>Glycated Hemoglobin--drug effects<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin--adverse effects<br/>Male<br/>Middle Aged<br/>Obesity<br/>Patient Dropouts<br/>Sulfonylurea Compounds--adverse effects<br/>Treatment Outcome<br/>Triglycerides--blood